Pharmaceuticals

Mike Jennings speaks at the London IP Summit on “Patenting computer-implemented inventions in the era of AI” Partner Mike Jennings spoke at the London IP Summit on the 16 October 2018 on the topic “Patenting computer-implemented inventions in the era of AI”. Mike spoke alongside representatives from IBM, Nokia, AT&T, ARM Holdings plc, NXP Semiconductors,… Read more »

The World IP Forum and APAA Conference, New Delhi, November 2018 Patent attorneys Julie Barrett-Major and Leonita Paulraj will be in New Delhi from 14 – 21 November, where they will attend the World IP Forum and APAA conferences. Whilst in New Delhi, Julie and Leonita will also attend the World IP Forum during 14-16 November…. Read more »

AA Thornton returns to PTMG in Dubrovnik! Consulting Patent Attorney Julie Barrett-Major  and Trade Mark Attorney Suzanne Power represented the firm at the Autumn Pharmaceutical Trade Marks Group (PTMG) conference in Dubrovnik, Croatia from 3rd to 6th October 2018. Julie and Susie hosted a tea and round table event at the Hotel Croatia Cavtat just before the start of… Read more »

Protection for cannabis-based IP in the wake of announcement of impending legalisation of medicinal cannabis The legalisation of medicinal and recreational cannabis in several US states, Canada and some European countries has resulted in a new economic market rising from what was previously an illegal trade. Meanwhile, in the UK, the recent cases of Billy… Read more »

EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit This article was updated: 8 October 2018 Introduction to the Falsified Medicines Directive Directive 2011/62/EU, better known as “The Falsified Medicines Directive” or “FMD”, came into force on 2 January 2013, with the aim of preventing falsified medicines from entering the legitimate supply chain… Read more »

WIPO Magazine has announced[1] the launch of a new tool linking patents and drugs: Pat-INFORMED The concept The World Intellectual Property Organization (WIPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), together with 20 participating global pharmaceutical companies, have joined forces to globalise the concept of the US’s ‘Orange Book’. Most drugs have… Read more »

Assessment of “plausibility” requirement from the EPO perspective Introduction This article considers how the EPO views the requirement of “plausibility”, which can arise during both the assessment of “sufficient disclosure” of the invention and “inventive step” in proceedings before the EPO, particularly in relation to inventions in the Pharmaceuticals and Life Sciences field. The EPO… Read more »

Swiss Biotech Day 2018, Basel, Switzerland Patent Attorneys Dr Craig Turner  and Julie Barrett- Major represented the firm at the Swiss Biotech Day 2018, in Basel, Switzerland, on 3 May 2018. According to European Biotechnology Magazine, “with more than 600 senior executives from the Swiss life science industry and from across Europe the annually held was as popular as… Read more »

CRISPR: the gene editing tool and related patents CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology is considered as one of the biggest innovations of the century in the biotechnology field and has gained a lot of attention worldwide, especially in the US and Europe in the area of Intellectual Property Rights. Research has… Read more »

Relaxing the Tension Between Publishing and Patenting: Practical Hints and Tips – Part two In the first part